artificial intelligence

The future of artificial intelligence.

Mobile App Development Cost Breakdown by App Type in 2026
When people talk about the cost of building a mobile app in 2026, they usually want a clean answer. A range. A benchmark.
By Samantha Blake4 days ago in Futurism
How Much Does Mobile App Development Cost in 2026?
When people ask how much mobile app development costs in 2026, they’re usually expecting a number. I used to answer that way too.
By Mary L. Rodriquez4 days ago in Futurism
When Denver Businesses Reach the Point of Needing a Mobile App
For years, I told myself we didn’t need a mobile app. We were a solid Denver business. Profitable. Stable. Growing at a steady pace. Our systems weren’t perfect, but they worked well enough. Email filled the gaps. Shared spreadsheets bridged the rest. When something broke, someone stayed late and fixed it.
By Ash Smith4 days ago in Futurism
Latin America Cyber Security Market Analysis: Growth, Trends, and Forecast (2026-2034)
The digital landscape in Latin America is evolving at breakneck speed, but this rapid technological expansion has a dark side. Recent studies indicate that organizations in the region now face an average of 2,716 cyber attacks per week, a figure that stands 39% higher than the global average. As businesses scramble to protect their digital assets, the Latin America cybersecurity market has become a critical focal point for investors, governments, and enterprise leaders alike.
By Joey Moore5 days ago in Futurism
Rajat Khare Steers Boundary Holding Through Withthegrid Exit, Signals Strategic Shift Toward Enduring Technologies
Boundary Holding, the Luxembourg-based deep-technology venture capital firm founded by Rajat Khare, has successfully completed its full exit from Withthegrid, a Netherlands-headquartered energy monitoring company. The deal, which was originally announced in early 2021, yielded the company a 2.0x multiplier on capital invested (MOIC) as per people who have been involved in the deal. More than just a milestone in financial terms this exit is an intentional reorientation of the portfolio by Boundary Holding as it prepares for the next phase of investment strategy.
By Chris Review5 days ago in Futurism
AI in Healthcare: How AI Is Improving Patient Care and Diagnostics
Healthcare has always moved more slowly than technology. Not because people resist change, but because mistakes cost lives.
By Emily Carter5 days ago in Futurism
The State of Cyber Threats in Germany in 2026
Key Takeaways: AI Breaks the Language Barrier: Generative AI has dissolved Germany's natural linguistic defense, driving a 300% surge in grammatically perfect phishing and deepfake attacks. Market Explosion: The German cybersecurity sector is projected to hit $37.9B by 2033, fueled by strict compliance needs like NIS2 and rising industrial espionage. The Sovereign Cloud War: US hyperscalers are forced to launch "Sovereign Clouds" to compete with local pure-players like StackIT and bypass the US CLOUD Act. Industry 4.0 Under Siege: Cyberattacks have shifted from office IT to factory floor OT, impacting 87% of manufacturers with sabotage on unpatched machinery. Quantum "Code Red": The BSI has set a 2026 deadline for critical infrastructure to adopt quantum-resistant encryption to counter "Store Now, Decrypt Later" threats.
By Joey Moore6 days ago in Futurism
Scalable AI Business Models: How High-Growth AI Startups Monetize Innovation. AI-Generated.
Artificial intelligence is no longer just a technological advantage—it has become a powerful business engine. High-growth AI startups are not only innovating faster than traditional companies but also monetizing that innovation through highly scalable business models. Unlike conventional tech firms, AI-driven businesses benefit from data compounding, automation, and continuous learning, enabling them to scale revenue without proportionally increasing costs.
By Timesofai6 days ago in Futurism
US Remote Patient Monitoring Market Surges to $29.13 Billion by 2030. AI-Generated.
The Remote Patient Monitoring (RPM) market in the United States is evolving rapidly, becoming a fundamental element of contemporary healthcare systems and a key focus for healthcare leaders across the country. The market was worth $14.15 billion in 2024 and is expected to grow to $16.09 billion in 2025. Forecasts indicate a strong compound annual growth rate (CAGR) of 12.6% until 2030, with a total market value of $29.13 billion anticipated by the close of the decade.
By Juan Martinez6 days ago in Futurism
Asia Pacific Pharmaceutical Drug Delivery Market Poised to Reach US$687.9 Million by 2031. AI-Generated.
The Asia Pacific pharmaceutical drug delivery market is experiencing transformative growth, advancing from US$479.7 million in 2026 to a projected US$687.9 million by 2031, representing a robust compound annual growth rate (CAGR) of 7.5% throughout the forecast period. This expansion—up from US$457.9 million in 2025—reflects fundamental shifts in regional healthcare infrastructure, disease management strategies, and therapeutic delivery innovation that C-suite executives and strategic decision-makers must understand to capitalize on emerging opportunities.
By Jennifer Reynolds6 days ago in Futurism
North America Next-Generation Sequencing Market Poised to Double to $11.63 Billion by 2030. AI-Generated.
The North American next-generation sequencing (NGS) market is entering a transformative growth phase, advancing from $6.15 billion in 2025 to a projected $11.63 billion by 2030, representing a compound annual growth rate (CAGR) of 13.6%. This acceleration signals a fundamental shift in how healthcare systems, biopharmaceutical enterprises, and research institutions approach disease diagnosis, drug development, and patient stratification.
By Juan Martinez6 days ago in Futurism
US Pharmaceutical Drug Delivery Market Poised to Reach $1.24 Billion by 2031. AI-Generated.
The United States pharmaceutical drug delivery market is entering a transformative growth phase, with valuations climbing from $910 million in 2025 to a projected $1.24 billion by 2031, representing a robust compound annual growth rate (CAGR) of 5.8%. This expansion signals a fundamental recalibration of how therapeutics reach patients, driven by the convergence of advanced biologics, digital health integration, and patient-centric delivery innovations that are redefining treatment paradigms across oncology, diabetes, and autoimmune disease management.
By Juan Martinez6 days ago in Futurism